# Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol

> **NCT05255744** · NA · TERMINATED · sponsor: **ResMed** · enrollment: 30 (actual)

## Conditions studied

- Obstructive Sleep Apnea

## Interventions

- **DEVICE:** Positive Airway Pressure (PAP) Therapy

## Key facts

- **NCT ID:** NCT05255744
- **Lead sponsor:** ResMed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-03-28
- **Primary completion:** 2025-05-06
- **Final completion:** 2025-05-31
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** The study was discontinued prior to initiation because startup activities could not be completed within the planned timelines.
- **Last updated:** 2026-04-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05255744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05255744, "Whitsundays (Nasal) Singapore External Clinical Study 1 Protocol". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05255744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*